Trial Profile
Effects Of The Long-Term Administration Of Nebivolol on the Clinical Symptoms, Exercise Capacity And Left Ventricular Function Of Patients With Diastolic Dysfunction (ELANDD)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Jan 2012
Price :
$35
*
At a glance
- Drugs Nebivolol (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- Acronyms ELANDD
- Sponsors Menarini
- 06 Dec 2011 Results published in the European Journal of Heart Failure.
- 13 Mar 2008 New trial record.